A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer ...

SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic and tumor genomic testing, commends the updated Prostate Cancer Guidelines from the ...

MOBILE, Ala. (WKRG) — According to the National Cancer Institute, up to 60% of the risks of prostate cancer are caused by inherited genes. Amanda Trulock, MS, CGC, from USA Health joined WKRG to ...

A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...

NEW HAVEN, Conn. (WTNH) — Understanding prostate cancer and the role genetics play can be very important for your health. With one in nine men affected by this disease, scientists at Hartford ...

Genetic screening for prostate cancer can help identify inherited risks early, guide treatment decisions, and protect your family’s health. At Fred Hutch Cancer Center, we offer expert genetic ...

Among men worldwide, prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths. As the world's population ages, the number of prostate cancer patients is expected ...

Men at higher genetic risk for prostate cancer had more than a threefold increased risk for early death from the disease, and about one third of these deaths may have been preventable through healthy ...

It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a specific form of the disease, which is particularly aggressive and deadly.

Prostate is one of the most commonly diagnosed cancers among men, particularly with advancing age. According to Dr Ahmed ...